ChuxiongYunzhi Phytopharmaceutical Co., Ltd. is a subsidiary of Yunnan Industrial Investment Holding Group Co., Ltd., a state-owned enterprise specializing in the production and operation of botanical bulk drugs and extracts.The predecessor of the company is Plant Medicine Factory of Yunnan Botanical Medicine Co., Ltd. In order to build the pharmaceutical sector of the group company and improve the plant medicine industry chain, the company took the country's new GMP in 2010 as an opportunity and adopted advanced design concepts and technical equipment. In 2013, the Company built a modern professional production base of plant medicine and traditional Chinese medicine extract.In July 2016, it was approved to formally separate from the assets of the parent company, Yunnan Botanical Medicine, and an independent legal person subsidiary, ChuxiongYunzhi Phytopharmaceutical Co., Ltd., was incorporated.
The company is located in Zhuangdian Pharmaceutical Industrial Park, Chuxiong Economic Development Zone. With an area of 40 mu and a registered capital of 80 million RMB, the Company employs 120 people and owns 15 varieties of plant raw materials.The main products include Notoginseng Total Saponins (oral and injection), Breviscapine (oral and injection), reserpine, Bergenin, Helicid and so on. After the completion of the first phase construction of the Company, annual processing of raw herbs reached 2,000 tons along with an annual output of 66 tons of raw material medicine plant scale. In 2016, the Company realized an annual output value of 150 million Yuan.
Adhering to the business philosophy of "from nature, for health care", taking advantage of the rich natural plant resources in Yunnan Province, focusing on the green industry and the development of large health products, and relying on the years of accumulated technology of Yunnan Pharmaceutical Co., Ltd.and the "Yunzhi" brand Influence, the Company has become one of Yunnan's main suppliers of specialty botanical bulk drugs.
In the future, ChuxiongYunzhi Pharmaceutical Co., Ltd. will take Notoginsenosides, Breviscapine, Bergenin and other specialty botanical bulk drugs as the leading products of plant medicine to develop customization upon requirement with the core of technological innovation and the aim of service extension. We will strive to develop the company into a leading technology company specializing in botanical bulk drugs, to provide both domestic and foreign customers with the safest and most effective quality products.